Pseudomonas aeruginosa is an intricate process in which various transcriptional activators (FleQ, FleR) and alternative sigma factors (RpoN/ 54 , RpoF/ 28 ) participate in the transcriptional regulation of the flagellar genes and operons (3, 23, 31, 33) . Of the two transcriptional activators identified in our laboratory, FleQ appears to be the highest-level positive regulator of flagellar biogenesis in P. aeruginosa.
Flagellar biogenesis in
Pseudomonas aeruginosa is an intricate process in which various transcriptional activators (FleQ, FleR) and alternative sigma factors (RpoN/ 54 , RpoF/ 28 ) participate in the transcriptional regulation of the flagellar genes and operons (3, 23, 31, 33) . Of the two transcriptional activators identified in our laboratory, FleQ appears to be the highest-level positive regulator of flagellar biogenesis in P. aeruginosa.
FleQ is homologous to the NtrC group of response regulators, which are part of a two-component signal transduction system, that works in concert with the alternative sigma factor RpoN (3). Typically, a two-component system consists of a phosphorelay between a sensor kinase and a response regulator pair (5) . The sensor kinase is activated by autophosphorylation when an environmental stimulus is sensed, and the response regulator is subsequently phosphorylated at the receiver domain. The response regulators are usually DNA binding proteins, and phosphorylation activates them to promote activation or repression of the downstream genes (5) . However, FleQ and several of its homologs that regulate flagellar biogenesis in other bacterial species, including FlrA of Vibrio cholerae (16) , FlaK of Vibrio parahaemolyticus (15) , and FlgR of Helicobacter pylori (30) , do not contain the hallmark residues in their receiver domains for phosphorylation and do not have a cognate sensor kinase encoded as a part of the same operon. Therefore, phosphorelay signaling does not appear to be the modulating mechanism that regulates the activities of these response regulators. Attempts to detect phosphorylation of FleQ in vitro were not successful in our laboratory, thus raising further doubts about the existence of a putative sensor kinase for FleQ (unpublished data). One of the mechanisms employed to accomplish posttranslational modulation of FleQ activity in P. aeruginosa involves direct protein-protein interactions with FleN, an antiactivator that represses FleQ-dependent transcriptional activation (8) . Whether fleQ is subject to transcriptional activation or repression in addition to posttranslational modulation has been a question. Preliminary data have demonstrated that FleQ synthesis occurs from the early log phase to the stationary phase of growth in shaken cultures of P. aeruginosa PAK (unpublished data), which suggests that constitutive expression occurs under these conditions. Whether the constitutive expression observed was driven by a constitutively expressed activator or merely by the housekeeping RNA polymerase holoenzyme is not clear.
The flagellar regulon is subject to hierarchical regulation in most of the flagellated bacteria. Among the flagellar regulators of monoflagellate bacteria, flgR, the fleQ homolog of H. pylori, has been proposed to be transcribed from a 70 -like promoter (30) . No information has been published concerning the transcriptional regulation of the fleQ homolgs flrA and flaK in V. cholerae and V. parahaemolyticus, respectively. However, flbD, the fleQ homolog of Caulobacter crescentus, along with the gene encoding its cognate sensor kinase, flbE, is positively regulated by CtrA, the master regulator which controls the initiation of DNA replication, DNA methylation, cell division, and flagellar biogenesis (10, 35) . In the peritrichous organisms Escherichia coli and Salmonella enterica serovar Typhimurium, transcriptional activators encoded by flhC and flhD are at the top of the hierarchy and are essential for the expression of flagellar genes (6) . The flhDC operon is controlled by a 70 promoter and a number of global regulatory factors (17) . There is evidence which suggests that the cyclic AMP receptor protein (CRP) activates and the histone-like nucleoid-structuring protein (H-NS) represses transcription of flhDC in E. coli (28) . In S. enterica serovar Typhimurium it has been demonstrated that the flhDC operon carries six possible transcriptional start sites, one of which is CRP dependent and one of which is CRP repressible (36) . Thus, flagellar biogenesis may be under both positive regulation and negative regulation in some bacteria.
Based on the known mechanisms of transcriptional regulation of FleQ homologs described above, fleQ could be envisaged to be regulated by one or more similar mechanisms. In this report, we provide evidence that fleQ and thus flagellar biogenesis in P. aeruginosa are 70 dependent and are negatively regulated by Vfr. Vfr is a homolog of E. coli CRP that functions as an activator for many genes, including lasR, that have been implicated in virulence and quorum sensing (2, 32, 34) . The physiological implications are discussed below.
MATERIALS AND METHODS
Bacterial strains, plasmids, and culture conditions. Strains and plasmids used in this paper are listed in Table 1 . All strains were routinely maintained by using Luria-Bertani (LB) (25) medium at 37°C. Antibiotics were used as necessary at the following concentrations: 100 g of ampicillin per ml and 20 g of tetracycline per ml for E. coli and 300 g of carbenicillin per ml and 100 g of tetracycline per ml for P. aeruginosa.
Homology searches. The Vfr binding sequence (AAATGTGATCTAGATCA CATTT) from the lasR promoter was used to search the complete P. aeruginosa genome (www.pseudomonas.com) with the program FindPattern in the Genetics Computer Group package (Accelrys, San Diego, Calif.). Nine mismatches were allowed.
Site-directed mutagenesis. Primers Qpmut1 and Qpmutcomp2 (Table 1 ) (Genomechanix Inc., Alachua, Fla.) were used with a Quick-change site-directed mutagenesis kit (Stratagene, La Jolla, Calif.) to mutate the Vfr binding site in the fleQ promoter according to the supplier's protocol. Primers Qp70mut1 and Qp70mutcomp2 and primers Qp70mut3 and Qp70mutcomp4 (Table 1 ) (Genomechanix Inc.) were similarly used to introduce 8-and 4-bp mutations in the putative Ϫ10 region of the fleQ promoter. Briefly, 20 ng of column-purified (Plasmid mini kit; Qiagen, Valencia, Calif.) plasmid template (pBS-fleQp) was used in a 50-l amplification reaction mixture consisting of 1 l of a solution containing each deoxynucleoside triphosphate at a concentration of 10 mM, 1 l of Pfu polymerase, 1.25 l of a 20 M solution of each primer, and 5 l of 10ϫ reaction buffer. The mixture was subjected to a cycling profile consisting of initial denaturation for 30 s at 95°C, followed by 13 cycles (Qpmut1 and Qpmitcomp2) or 18 cycles (Qp70mut1 and Qp70mutcomp2 or Qp70mut3 and Qp70mutcomp4) of denaturation at 95°C for 30 s, annealing at 60°C for 1 min, and extension at 68°C for 10 min. The reaction mixture contents were then treated with DpnI to digest the original plasmid template. One microliter of the postdigestion amplification reaction mixture was used to transform E. coli XL1 Blue cells, and transformants were selected on LB agar plates containing ampicillin. Several clones were sequenced, and a clone with the desired site-specific mutation was subsequently used for further subcloning. The plasmid with the mutated Vfr binding site (ACA 3 CGC) was designated pBS-fleQpmutV. The plasmids with the 8-bp (ATAAAATT 3 GCGCGCGC) and 4-bp (AAAT 3 GCGC) mutations in the Ϫ10 region were designated pBS-fleQpmutS8 and pBS-fleQpmutS4, respectively. The inserts from pBS-fleQpmutS8 and pBS-fleQpmutS4 were subcloned into pDN19lac⍀, generating plac⍀QmutS8 and plac⍀QmutS4, respectively.
Transformation and electroporation. Unless indicated otherwise, E. coli DH5␣ was the strain used for transformation (25) . Electroporation of P. aeruginosa was carried out as described elsewhere (7) .
PCR amplification of fragments for EMSAs and DNase I footprint assays. For electrophoretic mobility shift assays (EMSAs), 88-bp DNA fragments containing the fleQ promoter and the mutant fleQ promoter (ACA 3 CGC) were generated by PCR amplification by using oligonucleotide primers fleQ1F and fleQ1R (Table 1) (Integrated DNA Technologies, Inc., Coralville, Iowa). plac⍀Q and pBSfleQpmutV (Table 1 ) served as the templates. The high-fidelity polymerase Pfx (Stratagene) was used in the amplification reactions, which were performed according to the manufacturer's specifications. Radiolabeling of the DNA fragments was accomplished by inclusion of [␣-
32 P]dCTP (800 Ci/mmol; PerkinElmer Life Sciences Inc., Boston, Mass.) in the PCR mixtures. Following PCR amplification, the wild-type and mutant fleQ promoter fragments were purified by using the Promega Wizard DNA Cleanup system (Promega Corp., Madison, Wis.).
For the DNase I footprint assays, oligonuclotide primers fleQ2F and fleQ2R (Table 1 ) (Integrated DNA Technologies) were used to PCR amplify a 158-bp fragment containing the fleQ promoter region by using plac⍀Q as a template. The first 10 bp of each primer contained either a SalI (fleQ2F) or XhoI (fleQ2R) restriction site. PCR amplification and fragment purification were carried out as described above. The amplified fragment was cut with either SalI or XhoI to generate a 5Ј overhang that was end labeled with a single 5Ј [␣-
32 P]TTP (800 Ci/mmol; Perkin-Elmer Life Sciences Inc.) by using T7 polynucleotide kinase (Amersham Biosciences, Piscataway, N.J.) according to the manufacturer's directions.
Vfr purification. Vfr purification from P. aeruginosa PA103(pWNP28) was based on cAMP affinity chromatography and additional procedures described by Albus et al. (2), with modifications. Briefly, cultures were grown to an optical density at 600 nm (OD 600 ) of ϳ0.5, and then isopropyl-␤-D-thiogalactopyranoside (IPTG) was added to a final concentration of 1 mM to induce overexpression of Vfr. After an additional 6 h of incubation, the cells were harvested by centrifugation at 5,000 ϫ g for 15 min. The cell pellet was resuspended in a solution containing 100 mM Tris-HCl (pH 8.0), 50 mM KCl, 2 mM EDTA, 5 mM ␤-mercaptoethanol, and 1 mM sodium azide. A crude lysate was prepared by incubation of the solution with 200 g of lysozyme per ml for 20 min at room temperature. The lysate was adjusted to 125 mM Tris-HCl (pH 8.0), 25 mM MgSO 4 , and 1% Brij 35, incubated at 4°C for 10 min, and then passed through a 40K SLM-Aminco French pressure cell (Thermo Electron Corp., Waltham, Mass.) at a pressure of approximately 15,000 lb/in 2 . Cellular debris was removed by centrifugation at 16,000 ϫ g for 30 min at 4°C. An ammonium sulfate fractionation step was performed next; most of the Vfr protein precipitated between 50 and 65% ammonium sulfate saturation. This fraction was centrifuged at 27,000 ϫ g for 30 min at 4°C. The pellet was resuspended in a solution containing 50 mM Tris-HCl (pH 8.0), 2 mM EDTA, 5% glycerol, and 5 mM ␤-mercaptoethanol and dialyzed against the same buffer to remove the ammonium sulfate. The resulting solution was then applied to a cAMP-agarose column (Sigma Chemical Co., St. Louis, Mo.) as described by Ghosaini et al. (12) . Eluted fractions containing Vfr were pooled and dialyzed into a solution containing 10 mM sodium phosphate (pH 7.2), 2 mM EDTA, 5 mM ␤-mercaptoethanol, and 5% glycerol. The resulting solution was applied to an SP-Sephadex cationexchange column. Vfr-containing fractions were pooled and dialyzed into a solution containing 50 mM Tris-HCl (pH 7.2), 500 mM KCl, 0.2 mM EDTA, 0.2 mM dithiothreitol (DTT), and 50% glycerol for storage.
EMSAs. Binding reactions were performed as described by Devault et al. (9), with minor modifications. Briefly, the 20-l reaction mixtures contained the radiolabeled DNA fragments, with the radioactivity standardized to approximately 1,000 cpm (15 to 40 pM), and various concentrations of purified Vfr in a solution containing 10 mM Tris-HCl (pH 7.4), 100 mM KCl, 1 mM EDTA, 5% glycerol, 1 mM DTT, 50 g of bovine serum albumin per ml, 20 M cAMP, and 10 g of poly(dI-dC)-poly(dI-dC) (Amersham Biosciences Inc.) per ml. The reaction mixtures were incubated for 20 min at room temperature. Samples were electrophoresed on a preequilibrated 4% acrylamide-45 mM Tris-HCl-45 mM borate gel at 10 V/cm and 4°C. The upper buffer chamber contained 45 mM Tris-HCl, 45 mM borate (pH 8.0), and 20 M cAMP. The gels were dried and VOL. 184, 2002 Vfr REPRESSES TRANSCRIPTION OF fleQ 5241 exposed to Kodak X-Omat AR5 film overnight at Ϫ80°C with an intensifying screen. DNase I footprint assay. The DNase I footprint assay was based on the procedure of Ross et al. (24) . Binding reactions were performed by incubating purified Vfr with the radiolabeled DNA fragments in a solution containing 10 mM Tris-HCl (pH 7.4), 100 mM KCl, 10 mM MgCl 2 , 5% glycerol, 1 mM DTT, 50 g of bovine serum albumin per ml, and 20 M cAMP for 20 min at room temperature. DNase I (0.75 to 1.5 g/ml) was then added to the samples. The DNase I digestion reaction mixtures were incubated for 30 s at room temperature, and then the reactions were terminated by adding 12.5 mM (final concentration) EDTA, 200 mM (final concentration) sodium acetate, and 30% (vol/vol) (final concentration) phenol. The digestion products were ethanol precipitated and then resuspended in 0.5ϫ TBE buffer (45 mM Tris-HCl, 45 mM borate) containing 8 M urea, 0.5% bromophenol blue, and 0.5% xylene cyanol. The samples were analyzed on a 7 M urea-8% polyacrylamide gel to determine the regions protected by Vfr. Maxam-Gilbert sequencing reactions (19) were also performed with the radiolabeled DNA fragments to obtain sequence ladders for comparison with the footprint reaction mixtures.
Construction of promoter-lacZ fusions in the mini-CTX lacZ plasmid and chromosomal insertion of these fusions into the attB site. The wild-type and mutated fleQ promoter-containing inserts in pBS-fleQp and pBS-fleQpmutV were cloned as EcoRI-BamHI fragments in mini-CTX lacZ (4), generating CTX-fleQplacZ and CTX-fleQpmutVlacZ. E. coli S17-1 was transformed with these plasmids and the vector control mini-CTXlacZ. Matings were set up with the transformed E. coli S17-1 strain as the donor and P. aeruginosa PAK or PAO1 as the recipient. The exconjugants were selected on tetracyclinecontaining plates, and one colony was cultured further to electroporate the pFLP2 plasmid into it. Transformants were selected on carbenicillin-containing plates. Two colonies from each strain background were propagated in LB broth, and serial dilutions of the cultures were plated on LB medium and LB medium containing sucrose (5%). A few colonies from the sucrose-containing plate were examined for tetracycline sensitivity and carbenicillin sensitivity to ensure excision of the plasmid backbone and curing of the pFLP2 plasmid, respectively. The chromosomal integrants with the fleQp-lacZ fusion in PAK and PAO1 were designated PAK fleQp-lacZ and PAO fleQp-lacZ, respectively. The fleQpmutV-lacZ derivatives were designated PAK fleQpmutVlacZ and PAO fleQpmutV-lacZ. The controls with a promoterless lacZ integrated were designated PAK lacZ and PAO lacZ.
Motility assay. Plain 0.3% LB agar plates were used to test the motility of P. aeruginosa PAO9001, a vfr deletion mutant. To examine the effect of Vfr overexpression on the motility of strain PAK harboring either pMMB66EH or pWNP28, 0.3% LB agar plates containing carbenicillin without or with various concentrations of IPTG were used. The plates were stabbed with the strains and incubated at 37°C.
␤-Galactosidase assays. P. aeruginosa cultures were grown in LB broth with the appropriate antibiotic (if needed) to an OD 600 of ϳ0.8. The ␤-galactosidase assay was performed as described previously (20) . To study the effect of Vfr overexpression on the fleQ promoter activity, cultures were grown in LB broth with carbenicillin to an OD 600 of ϳ0.2, induced with 1 mM IPTG, and grown for an additional 6 h at 37°C with shaking. SDS-polyacrylamide gel electrophoresis and Western analysis. Bacteria were pelleted from 1 ml of each culture grown for 6 h (noninduced and IPTG induced). The cells were denatured by boiling in 2% sodium dodecyl sulfate (SDS)-1% ␤-mercaptoethanol-50 mM Tris-Cl (pH 7.5). Aliquots (5 l) of the samples were resolved on a 12.5% polyacrylamide gel, and the proteins were transferred to a polyvinylidene difluoride membrane by Western blotting. Following blocking in 3% skim milk for 2 h, the blot was treated with either anti-FleQ (1:2,000) or anti-Vfr (1:5,000) antibody as the first antibody and anti-rabbit immunoglobulin G-alkaline phosphatase conjugate as the second antibody. The blot was developed by using nitroblue tetrazolium and BCIP (5-bromo-4-chloro-3-indolylphosphate) as the color substrate (8).
RNA extraction. A 100-ml LB broth culture of P. aeruginosa PAK was grown at 37°C to an OD 600 of 0.6 with shaking, and the cells were harvested by centrifugation at 3,000 rpm for 20 min at 4°C (JA-10 rotor; Beckman). Total RNA was isolated from the cells by using the TRIZOL reagent (Invitrogen Life Technologies, Carlsbad, Calif.) and the supplier's protocol for isolating total bacterial RNA.
Primer extension analysis. Oligonucleotide RT2 was 5Ј end labeled in the presence of [␥-
32 P]ATP (3,000 Ci/mmol; Perkin-Elmer Life Sciences) and T4 polynucleotide kinase (Invitrogen Life Technologies). The labeled oligonucleotide (1 ϫ 10 6 cpm) was used in a primer extension reaction mixture (total volume, 20 l) consisting of 30 g of denatured (incubation at 65°C for 20 min) total RNA, 5 l of 5ϫ first-strand buffer, 1 l of a solution containing each deoxynucleoside triphosphate at a concentration of 10 mM, 1 l of a 100 mM DTT solution, 1 l of RNaseOUT, and 200 U of Superscript II RT. The reaction mixture was incubated at 42°C for 1 h, treated with 20 U of RNase H, phenolchloroform extracted, and ethanol precipitated. The precipitate was resuspended in 6 l of sequencing loading buffer, denatured at 95°C for 2 min, and subjected to 8% urea-polyacrylamide gel electrophoresis along with a sequencing ladder. The sequencing ladder was generated by Sanger's dideoxy sequencing method by using a Sequenase version 2.0 kit (U.S. Biochemical Corp., Cleveland, Ohio) with pBS-fleQpmutV as the template and RT2 as the primer. The gel was dried and subsequently autoradiographed.
In vitro transcription assay with E. coli RNA polymerase 70 holoenzyme. In vitro single-round runoff transcription analysis was performed by using E. coli RNA polymerase holoenzyme saturated with 70 (Epicentre Technologies, Madison, Wis.) and a DNA fragment containing the fleQ promoter. ScaI-BamHI fragments (289 bp) excised from plac⍀Q and plac⍀QmutS4 served as templates for the transcription assays. Briefly, 0.1 pmol of the DNA template was incubated with 0.2 U of the RNA polymerase holoenzyme, 10 Ci of [␣- .9], 6 mM MgCl 2 , 2 mM spermidine, 10 mM NaCl), and 1 l of RNaseOUT at 37°C for 1 h in a 10-l (total volume) mixture. Subsequently, the samples were treated with 1 U of RNase-free DNase for 15 min at 37°C, phenol-chloroform extracted, and ethanol precipitated. Each pellet was dissolved in RNA gel loading dye, and samples were electrophoresed in a 6% denaturing polyacrylamide gel containing 7 M urea and analyzed by autoradiography. A 50-bp DNA ladder served as the molecular weight marker.
RESULTS
Vfr binds to the fleQ promoter. Vfr has been shown to bind to specific sequences in the lasR, regA, and toxA promoters (K. J. Kanack, E. P. Ferrell, L. J. Runyen-Janecky, and S. E. H. West 160, 1996) . To identify additional Vfr binding sites, homology searches of the P. aeruginosa genome were conducted by using the Vfr binding site present in the lasR promoter. These searches revealed the putative Vfr binding site sequence AATTGACTAATCGTTCACATTT centered 116.5 bp upstream of the fleQ translational start (Fig.  1 ). This sequence is 62.5% similar to the lasR Vfr binding site sequence. In order to authenticate the putative Vfr binding site identified in the fleQ promoter, EMSAs were performed by using an 88-bp fragment containing this sequence and purified Vfr. The mobility of the 88-bp fleQ promoter fragment was retarded. The retardation was partial in the presence of 72.2 nM Vfr (Fig 2A) Transcriptional start sites t1 and t2, as determined by primer extension analysis, are shown. The bases mutagenized in the Vfr binding site and the Ϫ10 region are italicized and in boldface type, and the designations of the plasmids in which they were generated are indicated. The location of the RT2 primer used for primer extension is indicated by an arrow. The ScaI site is underlined.
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Vfr REPRESSES TRANSCRIPTION OF fleQ 5243 ment ( Fig. 2A ). This result indicated that the observed binding of Vfr to the fleQ promoter fragment was specific.
To confirm the identity of the Vfr DNA binding site in the fleQ promoter, DNase I footprinting was performed for a 158-bp fleQ promoter fragment that included the 88-bp region used in the EMSAs ( Fig. 1 and 3 ). In the presence of Vfr, the 5Ј-AAATTGACTAATCGTTCACATTTG-3Ј site was protected from DNase I cleavage. This region contains hypersensitive sites located at positions 11 and 19 on the coding strand and at positions 9 and 10 on the antisense strand of the protected sequence. This observation is similar to previous observations of DNase I hypersensitive sites in the promoters of other Vfr-regulated genes (Kanack et al., Abstr. 100th Gen. Meet. Am. Soc. Microbiol.).
Of the eight known and putative Vfr binding sites identified in the P. aeruginosa genome by subsequence search analysis, the CACA motif was highly conserved. To further confirm that the AAATTGACTAATCGTTCACATTTG site is the Vfr DNA binding site in the fleQ promoter, we substituted CGC for ACA by performing site-directed mutagenesis of pBSfleQp. EMSAs were performed for a 88-bp fleQ promoter fragment containing this mutation. At a Vfr concentration of 72.2 nM (Fig. 2B) , Vfr failed to bind to the fleQ promoter, probably because of its reduced affinity for the mutated site.
fleQ promoter activity is not downregulated in a PAO1 vfr mutant. Vfr activates transcription of toxA, regA, and lasR (2, 34) . To test whether the same was true for fleQ, the promoter activity of fleQ was assessed in PAO1 and the vfr deletion mutant PAO9001. The CTX-fleQplacZ plasmid containing the fleQ promoter cloned upstream of a promoterless lacZ gene and the mini-CTXlacZ plasmid were integrated into the attB site of the chromosome of each strain, and their ␤-galactosidase activities were quantified ( Table 2 ). The fleQ promoter activities were comparable in the wild-type and vfr mutant strains. The absence of Vfr in PAO9001 had no effect on the activity of the promoter, indicating that the fleQ promoter was not dependent on Vfr for transcriptional activation. To further confirm that the activation of fleQ transcription was not Vfr dependent, PAO1 and the vfr mutant PAO9001 were tested in a motility plate assay (data not shown). There was no motility defect in vfr mutant PAO9001.
vfr overexpression from a plasmid renders P. aeruginosa nonmotile. As Vfr binds to the fleQ promoter in vitro and does not activate fleQ transcription, we explored the possibility that Vfr may function as a repressor. To test whether overexpression of Vfr from an IPTG-inducible promoter would repress flagellar motility through fleQ, the vfr overexpression plasmid pWNP28 and the vector control pMMB66EH were electroporated into PAK and PAO1. The carbenicillin-resistant transformants were tested on motility agar plates containing carbenicillin and various concentrations of IPTG (0, 0.01, 0.1, and 1 mM). At IPTG concentrations of 0.1 and 1 mM, the PAK and PAO1 strains containing the inducible Vfr expression plasmid pWNP28 initially appeared to be nonmotile (6 h) (data not shown), but they displayed small motility zones upon further incubation (22 h), which were markedly reduced compared to that of the vector control. The motility profile of PAK under these conditions is shown in Fig. 4A .
FleQ production is downregulated following Vfr overproduction. To examine whether the repressive effect of Vfr on motility was due to repression of fleQ, a semiquantitative Western analysis of FleQ production was performed. Lysates of equivalent numbers of bacterial cells from IPTG-induced cultures of PAK containing either pWNP28, the vfr overexpression plasmid, or pMMB66HE, the vector control, were electrophoresed on an SDS-polyacrylamide gel and subjected to Western analysis with anti-FleQ (Fig. 4B ) and anti-Vfr (Fig.  4C ) polyclonal antibodies. The specificities of the anti-FleQ and anti-Vfr antibodies were examined prior to being used (data not shown). FleQ was barely detectable in PAK (pWNP28) (0.1 mM and 1.0 mM IPTG) compared to the control strain containing the vector. This indicated that downregulation of fleQ was one possible reason for the reduced motility observed with PAK(pWNP28). The amount of Vfr produced increased as the IPTG concentration increased (Fig. 4C) . For further experiments under Vfr overexpression conditions we used 1 mM as the inducing concentration of IPTG. To ascertain that the observed lower level of expression of FleQ in the vfr overexpression strain PAK(pWNP28) was due to transcriptional repression and not due to instability of FleQ under vfr-overexpressing conditions, the activities of the fleQ promoter-lacZ fusions integrated into the attB sites in strains PAK fleQp-lacZ and PAO fleQp-lacZ were assessed by performing a ␤-galactosidase reporter assay with vfr overexpression from pWNP28. PAK lacZ and PAO lacZ with promoterless lacZ inserted into the attB site served as controls. Strains overexpressing vfr repressed transcription from the wild-type fleQ promoter four-and twofold in PAK(pWNP28) and PAO1(pWNP28), respectively ( Table 3 ). The basal level of activity of the wild-type promoter in PAO1(pMMB66EH) was higher than that in PAK(pMMB66EH).
If downregulation of the fleQ promoter was due to repression by Vfr, an ACA-to-CGC mutation in the Vfr binding site of the fleQ promoter with reduced affinity for Vfr in an EMSA would be expected to be unresponsive or less responsive to Vfr-dependent downregulation. Therefore, we assessed the activity of an fleQpmutV-lacZ fusion that had been integrated into the attB sites of PAK and PAO1 containing the vfr overexpression plasmid pWNP28 (Table 3 ). The activity of fleQpmutV was higher than the activity of the wild-type fleQ promoter in both PAK and PAO1 carrying either the vfr overexpression plasmid pWNP28 or the vector pMMB66EH. The activity of the mutated promoter was not repressed by overproduction of Vfr in PAO1, indicating that Vfr was not able to bind to the fleQ promoter in vivo in strain PAO1. However, in PAK, the fleQpmutV promoter activity still displayed a twofold reduction under vfr overexpression conditions, indicating that the 3-bp ACA-to-CGC mutation in the Vfr binding site with reduced affinity for purified Vfr in vitro (Fig. 2B ) was still responsive to partial repression by Vfr in vivo.
Vfr binding site overlaps the putative ؊10 region and the transcriptional start sites of fleQ. We used primer extension analysis with PAK total RNA to determine the transcriptional start sites of fleQ. The transcriptional start sites mapped 121 bp (t1) and 118 bp (t2) upstream of the ATG initiation codon ( Fig. 1 and 5) , and both of these sites mapped within the Vfr binding site. Analysis of the nucleotide sequence upstream of the transcriptional start sites revealed a Ϫ10 region centered 9.5 bp upstream of the t2 transcript and a Ϫ35 region centered 34 bp upstream of the t2 transcript with five of six and three of six matches with the E. coli 70 consensus sequence, respectively (Fig. 1) . Four of the six bases comprising the Ϫ10 region were also part of the Vfr binding consensus region. These findings were consistent with a model in which the t2 transcript of fleQ is 70 regulated and occupancy of the Vfr binding site by Vfr could sterically hinder binding of the sigma factor ( 70 ) in the Ϫ10 region and deny access to the RNA polymerase to initiate transcription at either t1 or t2, thereby repressing fleQ transcription. However, it was uncertain whether fleQ was 70 regulated.
Mutations in the putative ؊10 region of the fleQ promoter result in significant reductions in its promoter activity. Two mutated derivatives of the fleQ promoter carrying an 8-bp mutation (ATAAAATT 3 GCGCGCGC) and a 4-bp mutation (AAAT 3 GCGC) in the Ϫ10 region were cloned into pDN19lac⍀, generating plac⍀QmutS8 and plac⍀QmutS4, respectively. plac⍀QmutS8 and plac⍀QmutS4 were electroporated into PAK, and their ␤-galactosidase activities were measured and compared. Both the mutated derivatives displayed a sixfold reduction in promoter activity compared to the wildtype promoter activity (Table 4) . Moreover, the residual ␤-galactosidase activities of the 8-and 4-bp mutated promoters were comparable to the residual activity of the promoterless vector control, indicating that there was total loss of transcriptional activity even with the less extensive 4-bp mutation.
E. coli RNA polymerase 70 holoenzyme initiates transcription from the fleQ promoter in an in vitro transcription assay. In order to determine whether transcription from the fleQ promoter could be initiated solely by the 70 -associated RNA polymerase, the fleQ promoter region was subjected to an in vitro transcription assay. Promoter sequences cloned in plac⍀Q and plac⍀QmutS4 were excised as ScaI-BamHI fragments and used in a cell-free in vitro transcription assay with the E. coli RNA polymerase holoenzyme saturated with 70 (Fig. 6) . The presence of a major transcript migrating at the expected position of the fleQ transcript (203 nucleotides) (Fig.  6, lane 1) and the absence of this transcript in the reaction performed with the Ϫ10 region mutated template (Fig. 6 , lane 2) confirmed that 70 was capable of transcribing fleQ. A smaller transcript (lane 2) specific to the mutated template could have resulted from an alternative transcription initiation site.
DISCUSSION
fleQ appears to be the highest-level activator in the hierarchical regulatory cascade involved in the flagellar biogenesis pathway of P. aeruginosa. It is essential for flagellar motility as an fleQ mutant does not assemble a flagellum nor does it synthesize detectable amounts of flagellin (3) . Moreover, at least eight of the various flagellar genes and operons studied to date appear to be directly and positively regulated by FleQ (7). FIG. 5 . Primer extension analysis of fleQ. Thirty micrograms of total RNA isolated from PAK was subjected to primer extension analysis with the RT2 primer and loaded in lane RT2. A sequencing reaction mixture (lanes C, T, A, and G) containing the same primer with pBS-fleQpmutV as the template was loaded and run on a denaturing urea-polyacrylamide gel simultaneously. The sequence of the region spanning the transcriptional start site is shown on the left. The residues marked with an asterisk are the probable start sites determined in this experiment, designated t1 and t2. Any mechanism that downregulates FleQ activity would have a negative impact on flagellar biogenesis and thereby motility and chemotaxis in this pathogen. We have identified FleN, an antiactivator for FleQ which posttranslationally downregulates FleQ activity by direct binding (8) . Whether in addition to this level of regulation there is any other mechanism that upregulates or downregulates the transcription of fleQ remains to be determined. Based on sequence homology, we found a putative Vfr binding site in the fleQ promoter, and we set out to ascertain its functional significance. The data presented here indicate that the Vfr binding site is an authentic site, as purified Vfr was able to bind to it, as demonstrated in the EMSAs (Fig. 2) , and to protect it from DNase I (Fig. 3) . The sequence of the protected region on both strands was consistent with the predicted consensus binding site.
Vfr is known to function as a transcriptional activator for the quorum-sensing regulatory protein lasR (2) . To determine the consequences of Vfr binding to the fleQ promoter, the promoter activity of FleQ was tested in PAO1 and a vfr mutant derivative of this strain, PAO9001 ( Table 2) . As there was no appreciable decline in the promoter activity in the vfr mutant, activation of fleQ transcription was not dependent on Vfr. We next explored whether repression by Vfr was a possibility. Since fleQ promoter activity in the vfr mutant was not greater than fleQ promoter activity in the wild-type strain, there was no evidence that suggested a repressor function for Vfr. We hypothesized that the amount of Vfr synthesized under our culture conditions was probably not sufficient for repression. Overexpression of vfr from pWNP28 under IPTG induction conditions in PAK (Fig. 4) and PAO1 (data not shown) repressed motility and downregulated the transcription of fleQ (Table 3) , indicating the ability of Vfr to repress fleQ as speculated. A comparison of the promoter activities in PAK and PAO1 (Table 3) revealed that although the fleQ promoter regions analyzed in strains PAK and PAO1 were identical, the basal activity of the promoter appeared to be greater in PAO1. Repression of the fleQ wild-type promoter by Vfr appears to be more effective in PAK (fourfold downregulation) than in PAO1 (twofold downregulation). As the sources of Vfr and the Vfr binding site sequences in the two strains tested are the same, involvement of an accessory factor (corepressor) that makes Vfr a better repressor in PAK than in PAO1 remains a possibility. The effector molecule that regulates Vfr activity in P. aeruginosa has not been identified. cAMP is one possibility and is required for Vfr activity in E. coli (32, 34) . Not much is known about the levels of cAMP in P. aeruginosa (21, 26) and specifically about quantitative differences (if any) in the cAMP levels in PAK and PAO1 which would enable us to explain our observations.
To understand how Vfr represses fleQ transcription, we mapped the fleQ transcriptional start sites. Two transcriptional start sites, t1 and t2, mapped within the Vfr binding site in PAK (Fig. 5) . Inspection of the sequences upstream of the transcriptional start sites revealed a 70 binding consensus (Fig  1) for the t2 transcript, indicating that it may be 70 dependent. In order to determine whether transcription of fleQ was
